$QWTR
Quest Water Global, Inc.

2024 Q2 Form 10-K Financial Statement

#000149315224014872 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $162.0K $595.5K
YoY Change -50.02%
% of Gross Profit
Research & Development $628.00 $3.320K
YoY Change -23.04% 1.22%
% of Gross Profit
Depreciation & Amortization $120.00 $500.00
YoY Change 50.15%
% of Gross Profit
Operating Expenses $140.4K $162.1K $596.0K
YoY Change -7.03% -49.99%
Operating Profit
YoY Change
Interest Expense $11.09K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$140.4K -$151.0K -$596.0K
YoY Change -7.03% -49.99%
Income Tax
% Of Pretax Income
Net Earnings -$140.4K -$151.0K -$596.0K
YoY Change -10.88% -50.84%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 131.9M shares 131.9M shares 131.9M shares
Diluted Shares Outstanding 131.9M shares 131.9M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents $3.00
Short-Term Investments
Other Short-Term Assets $1.530K $1.530K
YoY Change 40.37%
Inventory
Prepaid Expenses $4.822K $1.529K
Receivables
Other Receivables
Total Short-Term Assets $4.822K $1.532K $1.530K
YoY Change 3.77% 40.04% 40.37%
LONG-TERM ASSETS
Property, Plant & Equipment $417.00 $667.00 $670.00
YoY Change -54.53% -42.84% -42.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $417.00 $667.00 $670.00
YoY Change -54.53% -42.84% -42.74%
TOTAL ASSETS
Total Short-Term Assets $4.822K $1.532K $1.530K
Total Long-Term Assets $417.00 $667.00 $670.00
Total Assets $5.239K $2.199K $2.200K
YoY Change -5.84% -2.74% -2.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $62.39K $62.39K
YoY Change 65.49%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.837M $1.837M
YoY Change 44.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.837M $1.837M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.126M $1.837M $1.837M
YoY Change 34.47% 44.07% 44.07%
SHAREHOLDERS EQUITY
Retained Earnings -$12.31M -$11.84M
YoY Change 6.33% 4.99%
Common Stock $132.00 $132.00
YoY Change 0.0% 2.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.120M -$1.835M -$1.835M
YoY Change
Total Liabilities & Shareholders Equity $5.239K $2.199K $2.200K
YoY Change -5.84% -2.74% -2.65%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$140.4K -$151.0K -$596.0K
YoY Change -10.88% -50.84%
Depreciation, Depletion And Amortization $120.00 $500.00
YoY Change 50.15%
Cash From Operating Activities -$579.9K -$579.8K
YoY Change 3.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 579.8K $579.8K
YoY Change 3.75%
NET CHANGE
Cash From Operating Activities -579.9K -$579.8K
Cash From Investing Activities
Cash From Financing Activities 579.8K $579.8K
Net Change In Cash -40.00 $3.00
YoY Change -100.07%
FREE CASH FLOW
Cash From Operating Activities -$579.9K -$579.8K
Capital Expenditures
Free Cash Flow -$579.8K
YoY Change 2.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001487091
CY2023 dei Auditor Firm
AuditorFirmId
5525
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q4 QWTR Investment In Partnership Current
InvestmentInPartnershipCurrent
usd
CY2022 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
usd
CY2022 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023 QWTR Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1834904 usd
CY2023 dei Security12g Title
Security12gTitle
Common stock, $0.000001 par value
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
933755.95 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
131903029 shares
CY2023 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2023 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1529 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1094 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1532 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1094 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
667 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1167 usd
CY2023Q4 us-gaap Assets
Assets
2199 usd
CY2022Q4 us-gaap Assets
Assets
2261 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
62387 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
37698 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1837103 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1241152 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131903029 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131903029 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
132 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
132 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10000348 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10000348 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11835385 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11239372 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1238891 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2199 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2261 usd
CY2023 QWTR Automotive Expenses
AutomotiveExpenses
9021 usd
CY2022 QWTR Automotive Expenses
AutomotiveExpenses
10050 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
500 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
333 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
450000 usd
CY2023 QWTR Rent
Rent
21000 usd
CY2022 QWTR Rent
Rent
21000 usd
CY2023 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
3320 usd
CY2022 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
3280 usd
CY2023 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
20674 usd
CY2022 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
22033 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
629647 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
596013 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1191707 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-596013 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1191707 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-596013 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1191707 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.005
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.005
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.011
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.011
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131903029 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131903029 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105908762 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105908762 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1238891 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-596013 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1834904 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3714831 usd
CY2022Q4 us-gaap Share Price
SharePrice
0.065
CY2022 QWTR Stock Issued During Period Value Shares Issued For Debt
StockIssuedDuringPeriodValueSharesIssuedForDebt
3038000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
629647 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1191707 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1238891 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-596013 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1191707 usd
CY2023 us-gaap Depreciation
Depreciation
500 usd
CY2022 us-gaap Depreciation
Depreciation
333 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
629647 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
435 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1094 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
24689 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
22598 usd
CY2023 QWTR Increase Decrease In Due To Related Company
IncreaseDecreaseInDueToRelatedCompany
-8568 usd
CY2022 QWTR Increase Decrease In Due To Related Company
IncreaseDecreaseInDueToRelatedCompany
-21359 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-579827 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-561582 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1500 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1500 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
579830 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
558855 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
579830 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
558855 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4227 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4227 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3 usd
CY2023Q4 QWTR Working Capital Deficiency
WorkingCapitalDeficiency
1835571 usd
CY2023Q4 QWTR Liability To Principal Stockholders Due To Working Capital Deficiency
LiabilityToPrincipalStockholdersDueToWorkingCapitalDeficiency
1733443 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11835385 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zG1JXev2XqX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span id="xdx_862_z9W3IiiYnJx5">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1094 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1094 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1167 usd
CY2022Q4 us-gaap Assets
Assets
2261 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
37698 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1241152 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131903029 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131903029 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
132 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10000348 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11239372 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1238891 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2261 usd
CY2022 QWTR Automotive Expenses
AutomotiveExpenses
10050 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
333 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
450000 usd
CY2022 QWTR Office And Miscellaneous Expense
OfficeAndMiscellaneousExpense
3490 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
51874 usd
CY2022 QWTR Rent
Rent
21000 usd
CY2022 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
3280 usd
CY2022 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
22033 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
629647 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1191707 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1191707 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1191707 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.011
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.011
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105908762 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105908762 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1191707 usd
CY2022 us-gaap Depreciation
Depreciation
333 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
629647 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1094 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
22598 usd
CY2022 QWTR Increase Decrease In Due To Related Company
IncreaseDecreaseInDueToRelatedCompany
-21359 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-561582 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1500 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1500 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
558855 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
558855 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4227 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4227 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
608484 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1212320 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131903029 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105908762 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6300000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.10 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P10Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8500000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.10
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2200000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.10
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6300000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6300000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.10
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0317 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.0666 pure
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.10
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.10
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M14D
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-596013 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1191707 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
125000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
250000 usd
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
33000 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
30000 usd
CY2022 QWTR Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
132000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
158000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
148000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1462000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1304000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1462000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1304000 usd

Files In Submission

Name View Source Status
0001493152-24-014872-index-headers.html Edgar Link pending
0001493152-24-014872-index.html Edgar Link pending
0001493152-24-014872.txt Edgar Link pending
0001493152-24-014872-xbrl.zip Edgar Link pending
aud_001.jpg Edgar Link pending
aud_002.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
qwtr-20231231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qwtr-20231231_cal.xml Edgar Link unprocessable
qwtr-20231231_def.xml Edgar Link unprocessable
qwtr-20231231_lab.xml Edgar Link unprocessable
qwtr-20231231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending